Ångström AI
San Francisco
About Ångström AI
Angstrom AI leverages GenAI-based molecular simulations to replace wet lab experiments in pre-clinical drug development.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $500.0K
- Funding stage: Seed
- Last round: Pre-Seed (Sep 2024)
- Website: angstrom-ai.com#home
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/ngstr-m-ai-11080 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.